Top drug in that 12,000 drug screening study gets a Phase II study in Covid: https://news.yale.edu/2020/07/27/yale-lead-trial-potential-covid-19-treatment AI Therapeutics LAM022a apilimod. I still wonder how brilacidin didn't make the cut.
Market Data 
Markets
AI
